申请人:UNIV VANDERBILT
公开号:WO2021101927A1
公开(公告)日:2021-05-27
Substituted N-heteroaryl sulfonamide compounds inhibit WDR5-MYC interactions, and the compounds and their pharmaceutical compositions are useful for treating disorders and conditions in a subject such as cancer cell proliferation.
N-杂环磺胺化合物替代物抑制WDR5-MYC相互作用,这些化合物及其药物组合物适用于治疗主体中的疾病和状况,如癌细胞增殖。